Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature (Q38218948)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature
scientific article

    Statements

    Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature (English)
    Stefan K Alig
    Martin Dreyling
    Bettina Seppi
    Benedikt Aulinger
    Lukas Witkowski
    Christina T Rieger
    554-557

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit